The Andrew & Erna Viterbi Professor of Electrical Engineering and Computer Science at MIT spoke about a new way of continuous monitoring for patients with MS and neurodegenerative disorders, discovering changes in quality of life and new biomarkers.
"I think the development in health and in healthcare in general in the future is going to see a lot of integration between medicine and computer science and the innovations are going to come from the combination."
In a presentation at the Americas Committee for Treatment and Research in MS (ACTRIMS) Forum in Dallas, Texas, Dina Katabi, PhD, the Andrew and Erna Viterbi Professor of Electrical Engineering and Computer Science at MIT, spoke about how there’s a great opportunity in CNS diseases, particularly multiple sclerosis, to address therapeutics by integrating new types of cutting-edge biosensors and machine learning to measure disease activity.
Katabi explained that currently they have the only sensor that can extract from wireless signals the symptoms and physiological signals patients report purely by analyzing the radio signals in the environment.
To dive deeper in Katabi’s current research and future study plans, NeurologyLive sat down with her at the ACTRIMS Forum.
Related Content:Americas Committee for Treatment and Research in Multiple Sclerosis | Conferences | News | Multiple Sclerosis